In addition, the expression of the inflammatory cytokine IL-1β is significantly increased in periodontitis tissues, and an in vitro study demonstrated that IL-1β-treated PDLSCs showed impaired osteogenesis potential (Fawzy El-Sayed et al., 2019). Here, IL1B is linked to periodontitis.